BEYONTTRA
BEYONTTRA is a medicine authorised by Swissmedic under authorisation number 70089. The authorisation holder is Bayer (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 18 December 2025 and the authorisation is limited until 17 December 2030. ATC code C01EB25 places the medicine in the group Cardiac therapy.
| Authorisation number | 70089 |
|---|---|
| Name | BEYONTTRA |
| Full name | BEYONTTRA, Filmtabletten |
| Authorisation holder | Bayer (Schweiz) AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C01EB25 |
| First authorisation | 18 December 2025 |
| Authorisation validity | 17 December 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | BEYONTTRA, Filmtabletten | B | 18 December 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 120 | Tablette(n) | C01EB25 | 02.99.0. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is BEYONTTRA authorised in Switzerland?
Yes. BEYONTTRA is authorised by Swissmedic under authorisation number 70089, data as of 01 September 2026. The authorisation is limited until 17 December 2030.
Which dispensing category does BEYONTTRA have?
BEYONTTRA is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of BEYONTTRA?
The authorisation holder is Bayer (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.